Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Artificial liver support 1985].

G Brunner, H Lösgen

    Leber, Magen, Darm
    |September 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Two main hospital treatments support liver function in hepatic failure: plasma exchange and dialysis/hemofiltration. These methods reduce toxins and replace vital substances, but require careful application to avoid complications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance.

    International journal of obesity (2005)·2015
    Same author

    A nine-gene signature predicting clinical outcome in cutaneous melanoma.

    Journal of cancer research and clinical oncology·2012
    Same author

    GAB2 induces tumor angiogenesis in NRAS-driven melanoma.

    Oncogene·2012
    Same author

    Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease.

    Alimentary pharmacology & therapeutics·2012
    Same author

    Adhesive function of newcastle-disease virus hemagglutinin in tumor-host interaction.

    International journal of oncology·2011
    Same author

    Benefits and costs of improved IEQ in U.S. offices.

    Indoor air·2011
    Same journal

    [Cost savings with preoperative ambulatory diagnosis in elective gastrointestinal operations].

    Leber, Magen, Darm·1996
    Same journal

    [Pseudo-esophagitis in antacid abuse].

    Leber, Magen, Darm·1996
    Same journal

    [Aortoduodenal fistula as the cause of gastrointestinal hemorrhage].

    Leber, Magen, Darm·1996
    Same journal

    [Positive effect of ursodeoxycholic acid on liver enzymes in autoimmune hepatitis with little activity--a pilot study].

    Leber, Magen, Darm·1996
    Same journal

    [Diagnosis and therapy of Helicobacter pylori infection. Guidelines of the German Society of Digestive and Metabolic Diseases. Working Group of the German Society of Digestive and Metabolic Diseases].

    Leber, Magen, Darm·1996
    Same journal

    [Diagnosis and therapy of portal hypertension].

    Leber, Magen, Darm·1996
    See all related articles

    Area of Science:

    • Hepatology and Nephrology
    • Biochemistry and Toxicology

    Context:

    • Hepatic failure presents a critical challenge in patient management.
    • Existing treatments for liver support are limited in scope and application.
    • Hospital settings require specific conditions and safety protocols for advanced therapies.

    Purpose:

    • To review and compare established hospital-based techniques for supporting liver function in hepatic failure.
    • To highlight the mechanisms, benefits, and limitations of plasma exchange, dialysis, and hemofiltration.
    • To briefly mention specialized treatments like liver perfusion and transplantation.

    Summary:

    • Plasma exchange removes toxins and replaces coagulation factors but requires 3-4 day intervals to prevent complications.
    • Dialysis and hemofiltration clear water-soluble toxins and excess amino acids, with amino acid supplementation preventing essential nutrient loss.

    Related Experiment Videos

  • These methods are suitable for equipped hospitals, offering crucial support for patients with liver dysfunction.

    • Impact:

    • Provides a comparative overview of viable liver support strategies in clinical settings.
    • Informs clinicians about the appropriate use and potential risks associated with different treatment modalities.
    • Contributes to the understanding of managing hepatic failure through extracorporeal therapies.